Fundraising FoxChameleon Biosciences
Berkeley, US · Founded 2017 · Delaware corporation · 4 known investors
Find your way into Chameleon Biosciences
1,273 people in our graph can introduce you to the Chameleon Biosciences team.
Sign up to see every warm intro you have to Chameleon Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chameleon Biosciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Chameleon Biosciences was founded in 2017 by Genine Winslow.
GW
Genine WinslowFounderGenine Winslow was previously CEO of Editpep, a company developing CRISPR-based peptide delivery to the central nervous system, and has advised early-stage cell and gene therapy programs through G Winslow Consulting, drawing on expertise in immunology and genetic medicine drug development.
RG
Ran GengNamed on SEC filing
WW
Winnie WanNamed on SEC filing
Investors · 4
Berkeley SkyDeck Fundlisted by Berkeley SkyDeck FundBerkeley · $200K
How we know: Berkeley SkyDeck Fund's portfolio page · Not right? Tell us
Future Planet Capitallisted by Future Planet CapitalLondon
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 1 round · 2021
▶$10.6MraisedMar 2021 · 23 investors · BiotechnologyRule 506(b)
▶$10.6MraisedMar 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ran GengDirector
- Winnie WanDirector
- Genine A. WinslowExecutive Officer, Director
- Offering amount
- $23M
- Amount sold
- $10.6M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Chameleon Biosciences?
- Chameleon Biosciences was founded by Genine Winslow in 2017.
- Who are Chameleon Biosciences's investors?
- Chameleon Biosciences's investors include Berkeley SkyDeck Fund, Future Planet Capital, Solasta Ventures, Tachyon Ventures.
- How much funding has Chameleon Biosciences raised?
- Chameleon Biosciences has disclosed $10.6M raised across 1 round.
- Where is Chameleon Biosciences headquartered?
- Chameleon Biosciences is headquartered in Berkeley, US.